Epigenetic mechanisms driving tumor supportive microenvironment differentiation and function a role in cancer therapy?

Marvin Sylvestre (1, 2) , Karin Tarte (1, 3) , David Roulois (1, 2, 4)

1 MICMAC - Microenvironment, Cell Differentiation, Immunology and Cancer
2 Etablissement Français du Sang Bretagne
3 Centre Hospitalier Universitaire de Rennes [CHU Rennes] = Rennes University Hospital [Ponchaillou]
4 Cancéropôle Grand-Ouest [Bretagne-Centre-Pays de Loire]

The tumor microenvironment (TME) plays a central role in tumor development and drug resistance. Within TME, the stromal cell subset, called cancer-associated fibroblasts, is a heterogeneous population originating from poorly characterized precursors. Since cancer-associated fibroblasts do not acquire somatic mutations, other mechanisms like epigenetic regulation, could be involved in the development of these cells and in the acquisition of tumor supportive phenotypes. Moreover, such epigenetic modulations have been correlated to the emergence of an immunosuppressive microenvironment facilitating tumor evasion. These findings underline the need to deepen our knowledge on epigenetic mechanisms driving TME development and function, and to understand the impact of epigenetic drugs that could be used in future to target both tumor cells and their TME.

Mots clés: epigenetic; microenvironment; cancer; cancer-associated fibroblasts

Domaines: Cancer

Marvin Sylvestre, Karin Tarte, David Roulois. Epigenetic mechanisms driving tumor supportive microenvironment differentiation and function a role in cancer therapy?. Epigenomics, 2020, 12 (2), pp.157-169. ⟨10.2217/epi-2019-0165⟩. ⟨hal-02442385⟩